CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells

Experimental Cell Research

Volumn 313, Issue 19, 2007, Pages 4051-4065

  Jones, Jon ^a   Marian, Dana ^a   Weich, Eva ^a   Engl, Tobias ^a   Wedel, Steffen ^a   Relja, Borna ^a   Jonas, Dietger ^a   Blaheta, Roman A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Adhesion; Chemotaxis; CXCL12; CXCR4; Integrins; Renal cell carcinoma

Indexed keywords

ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; COLLAGEN; FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; INTEGRIN LINKED KINASE; INTEGRIN RECEPTOR; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SCLEROPROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 35448994852     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.07.001     Document Type: Article

References (36)

1. Zlotnik A. Chemokines and cancer. Int. J. Cancer 119 (2006) 2026-2029
2. Jones J., Otu H., Spentzos D., Kolia S., Inan M., Beecken W.D., Fellbaum C., Gu X., Joseph M., Pantuck A.J., Jonas D., and Libermann T.A. Gene signatures of progression and metastasis in renal cell cancer. Clin. Cancer Res. 11 (2005) 5730-5739
3. Schrader A.J., Lechner O., Templin M., Dittmar K.E., Machtens S., Mengel M., Probst-Kepper M., Franzke A., Wollensak T., Gatzlaff P., Atzpodien J., Buer J., and Lauber J. CXCR4/CXCL12 expression and signalling in kidney cancer. Br. J. Cancer 86 (2002) 1250-1256
4. Zagzag D., Krishnamachary B., Yee H., Okuyama H., Chiriboga L., Ali M.A., Melamed J., and Semenza G.L. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res. 65 (2005) 6178-6188
5. Pan J., Mestas J., Burdick M.D., Phillips R.J., Thomas G.V., Reckamp K., Belperio J.A., and Strieter R.M. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol. Cancer 5 (2006) 56
6. Engl T., Relja B., Marian D., Blumenberg C., Muller I., Beecken W.D., Jones J., Ringel E.M., Bereiter-Hahn J., Jonas D., and Blaheta R.A. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 8 (2006) 290-301
7. Singh S., Singh U.P., Grizzle W.E., and Lillard Jr. J.W. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab. Invest. 84 (2004) 1666-1676
8. Huang Q., Shen H.M., Shui G., Wenk M.R., and Ong C.N. Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway. Cancer Res. 66 (2006) 5807-5815
9. Rissanen J., Korhonen M., Lehto V.P., and Virtanen I. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms. J. Pathol. 200 (2003) 157-167
10. Brenner W., Benzing F., Gudejko-Thiel J., Fischer R., Farber G., Hengstler J.G., Seliger B., and Thuroff J.W. Regulation of beta1 integrin expression by PKCepsilon in renal cancer cells. Int. J. Oncol. 25 (2004) 1157-1163
11. Oertl A., Relja B., Makarevic J., Weich E., Hofler S., Jones J., Jonas D., Bratzke H., Baer P.C., and Blaheta R.A. Altered expression of beta1 integrins in renal carcinoma cell lines exposed to the differentiation inducer valproic acid. Int. J. Mol. Med. 18 (2006) 347-354
12. Korhonen M., Sariola H., Gould V.E., Kangas L., and Virtanen I. Integrins and laminins in human renal carcinoma cells and tumors grown in nude mice. Cancer Res. 54 (1994) 4532-4538
13. Roy-Chaudhury P., Hillis G., McDonald S., Simpson J.G., and Power D.A. Importance of the tubulointerstitium in human glomerulonephritis: II. Distribution of integrin chains beta 1, alpha 1 to 6 and alpha V. Kidney Int. 52 (1997) 103-110
14. Baraldi A., Zambruno G., Furci L., Ballestri M., Tombesi A., Ottani D., Lucchi L., and Lusvarghi E. Beta 1 and beta 3 integrin upregulation in rapidly progressive glomerulonephritis. Nephrol. Dial. Transplant. 10 (1995) 1155-1161
15. Shi Y., Tu Z., Wang W., Li Q., Ye F., Wang J., Qiu J., Zhang L., Bu H., and Li Y. Homologous peptide of connective tissue growth factor ameliorates epithelial to mesenchymal transition of tubular epithelial cells. Cytokine 36 (2006) 35-44
16. Kuwada S.K. Drug evaluation: volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr. Opin. Mol. Ther. 9 (2007) 92-98
17. McNeel D.G., Eickhoff J., Lee F.T., King D.M., Alberti D., Thomas J.P., Friedl A., Kolesar J., Marnocha R., Volkman J., Zhang J., Hammershaimb L., Zwiebel J.A., and Wilding G. Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin. Cancer Res. 11 (2005) 7851-7860
18. Beekman K.W., Colevas A.D., Cooney K., Dipaola R., Dunn R.L., Gross M., Keller E.T., Pienta K.J., Ryan C.J., Smith D., and Hussain M. Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design. Clin. Genitourin. Cancer 4 (2006) 299-302
19. Cianfrocca M.E., Kimmel K.A., Gallo J., Cardoso T., Brown M.M., Hudes G., Lewis N., Weiner L., Lam G.N., Brown S.C., Shaw D.E., Mazar A.P., and Cohen R.B. Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours. Br. J. Cancer 94 (2006) 1621-1626
20. Bockhorn M., Roberge S., Sousa C., Jain R.K., and Munn L.L. Differential gene expression in metastasizing cells shed from kidney tumors. Cancer Res. 64 (2004) 2469-2473
21. Winterwood N.E., Varzavand A., Meland M.N., Ashman L.K., and Stipp C.S. A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5. Mol. Biol. Cell 17 (2006) 2707-2721
22. Skalski M., and Coppolino M.G. SNARE-mediated trafficking of alpha5beta1 integrin is required for spreading in CHO cells. Biochem. Biophys. Res. Commun. 335 (2005) 1199-1210
23. Powelka A.M., Sun J., Li J., Gao M., Shaw L.M., Sonnenberg A., and Hsu V.W. Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 5 (2004) 20-36
24. Kato K., Shiga K., Yamaguchi K., Hata K., Kobayashi T., Miyazaki K., Saijo S., and Miyagi T. Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling. Biochem. J. 394 (2006) 647-656
25. Shi Q., Bao S., Song L., Wu Q., Bigner D.D., Hjelmeland A.B., and Rich J.N. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26 (2007) 4084-4094
26. Graff J.R., Deddens J.A., Konicek B.W., Colligan B.M., Hurst B.M., Carter H.W., and Carter J.H. Integrin-linked kinase expression increases with prostate tumor grade. Clin. Cancer Res. 7 (2001) 1987-1991
27. Zeng Z.Z., Jia Y., Hahn N.J., Markwart S.M., Rockwood K.F., and Livant D.L. Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res. 66 (2006) 8091-8099
28. Thamilselvan V., Craig D.H., and Basson M.D. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J. 21 (2007) 1730-1741
29. Hapke S., Kessler H., Luber B., Benge A., Hutzler P., Hofler H., Schmitt M., and Reuning U. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction. Biol. Chem. 384 (2003) 1073-1083
30. Sawhney R.S., Cookson M.M., Omar Y., Hauser J., and Brattain M.G. Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. J. Biol. Chem. 281 (2006) 8497-8510
31. Sawai H., Okada Y., Funahashi H., Matsuo Y., Takahashi H., Takeyama H., and Manabe T. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol. Cancer 4 (2005) 37
32. Desban N., Lissitzky J.C., Rousselle P., and Duband J.L. alpha1beta1-integrin engagement to distinct laminin-1 domains orchestrates spreading, migration and survival of neural crest cells through independent signaling pathways. J. Cell Sci. 119 (2006) 3206-3218
33. Manohar A., Shome S.G., Lamar J., Stirling L., Iyer V., Pumiglia K., and DiPersio C.M. Alpha 3 beta 1 integrin promotes keratinocyte cell survival through activation of a MEK/ERK signaling pathway. J. Cell Sci. 117 (2004) 4043-4054
34. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E., Sunshine M.J., Littman D.R., Kuo C.J., Wei K., McMaster B.E., Wright K., Howard M.C., and Schall T.J. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203 (2006) 2201-2213
35. Hartmann T.N., Burger J.A., Glodek A., Fujii N., and Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 24 (2005) 4462-4471
36. Cashen A.F., Nervi B., and DiPersio J. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol. 3 (2007) 19-27